Efficacy of second-line treatment for gemcitabine-refractory unresectable pancreatic cancer in a real-world setting

Efficacy of second-line treatment for gemcitabine-refractory unresectable pancreatic cancer in a real-world setting

Abstract Background This study aimed to compare the benefits and identify the best second-line treatment regimen for gemcitabine-refractory unresectable pancreatic cancers. Patients and methods This retrospective analysis included 144 patients with unresectable pancreatic cancer who underwent a gemc...

Full description

Saved in:
Bibliographic Details
Main Authors: Qianqian Wang, Nan Lv, Dong Xu, Yang Wu, Junli Wu, Wentao Gao, Jishu Wei, Bin Xiao, Min Tu, Kuirong Jiang
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Cancer
Subjects:
Pancreatic Cancer
Second-line treatment
mFFX
Chemotherapy
PS
Online Access:https://doi.org/10.1186/s12885-025-14601-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14601-2

Similar Items